Hunger, S., Saha, V., Devidas, M., Valsecchi, M., Foster, J., Cazzaniga, G., et al. (2017). CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL). Intervento presentato a: 59th American Society of Hematology (ASH) Annual Meeting and Exposition, Atlanta, Georgia [10.1182/blood.V130.Suppl_1.98.98].
CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Valsecchi, MG;Cazzaniga, G;Biondi, A
2017
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Hunger-2017-Blood-VoR.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Licenza open access specifica dell’editore
Dimensione
115.51 kB
Formato
Adobe PDF
|
115.51 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
